Medications for Epilepsy Complex Partial

27 results
  • Coupler LLC
    Usage: Carbamazepine extended-release capsules are indicated as an anticonvulsant for treating partial seizures with complex symptomatology, generalized tonic-clonic seizures, and mixed seizure patterns. They are also used for managing pain associated with true trigeminal neuralgia and glossopharyngeal neuralgia, but not for minor pain relief.
  • Depakote

    (Divalproex Sodium)
    AbbVie Inc.
    Usage: Depakote ER is indicated for treating acute manic or mixed episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. It is not effective for acute migraine treatment. Considerations regarding pregnancy and potential risks are crucial for women of childbearing potential.
  • Depakote (divalproex sodium)

    (Divalproex Sodium)
    REMEDYREPACK INC.
    Usage: Depakote ER is indicated for treating acute manic or mixed episodes in bipolar disorder, as well as for monotherapy and adjunctive therapy in complex partial and absence seizures in patients aged 10 and older. It is also approved for migraine prophylaxis but not for acute treatment.
  • Dilantin (phenytoin sodium)

    (phenytoin sodium)
    Physicians Total Care, Inc.
    Usage: Dilantin is indicated for controlling generalized tonic-clonic (grand mal) and complex partial seizures, as well as for preventing and treating seizures during or after neurosurgery. Serum level monitoring may be required for optimal dosage adjustments.
  • Bryant Ranch Prepack
    Usage: Divalproex sodium extended-release tablets are indicated for the treatment of acute manic or mixed episodes associated with bipolar disorder, monotherapy and adjunctive therapy for complex partial seizures, and migraine prophylaxis. Use in pregnant women or those planning pregnancy is contraindicated due to risks of fetal harm.
  • Aurobindo Pharma Limited
    Usage: Divalproex sodium delayed-release tablets are indicated for treating manic episodes in bipolar disorder, as well as for monotherapy and adjunctive therapy in epilepsy (complex partial and absence seizures). They are also used for migraine prophylaxis but not for acute treatment. Not suitable for pregnant women or those planning pregnancy.
  • Mylan Institutional LLC
    Usage: Divalproex sodium extended-release tablets are indicated for treating acute manic or mixed episodes in bipolar disorder, epilepsy (complex partial and absence seizures), and for migraine prophylaxis. It should not be used in women of childbearing potential without effective contraception due to significant fetal risks.
  • Aphena Pharma Solutions - Tennessee, LLC
    Usage: Divalproex sodium is indicated for treating manic episodes of bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. Long-term efficacy in mania is not established. It is contraindicated in pregnant women due to risks of fetal harm.
  • American Health Packaging
    Usage: Divalproex sodium delayed-release capsules are indicated for the treatment of complex partial seizures in adults and pediatric patients aged 10 and older, as well as for simple and complex absence seizures. It can be used as monotherapy or adjunctive therapy, but has limitations for use in women of childbearing potential.
  • American Health Packaging
    Usage: Divalproex sodium delayed-release tablets are indicated for treating manic episodes in bipolar disorder, complex partial seizures, simple and complex absence seizures, and for migraine prophylaxis. It is not effective for acute migraine treatment and should be avoided in pregnant women or those planning pregnancy due to potential risks.